-
Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2.
J Virol. 2000 Feb;74(4):1727-35
PMID: 10644343
-
A role for SKIP in EBNA2 activation of CBF1-repressed promoters.
J Virol. 2000 Feb;74(4):1939-47
PMID: 10644367
-
LMP1 of Epstein-Barr virus suppresses cellular senescence associated with the inhibition of p16INK4a expression.
Oncogene. 2000 Apr 13;19(16):2002-13
PMID: 10803461
-
Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site.
J Virol. 2000 Jun;74(11):5151-60
PMID: 10799590
-
STATs in oncogenesis.
Oncogene. 2000 May 15;19(21):2474-88
PMID: 10851046
-
Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors.
Oncogene. 2000 May 15;19(21):2548-56
PMID: 10851053
-
Epstein-Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells.
J Virol. 2000 Jul;74(14):6324-32
PMID: 10864642
-
The bfl-1 gene is transcriptionally upregulated by the Epstein-Barr virus LMP1, and its expression promotes the survival of a Burkitt's lymphoma cell line.
J Virol. 2000 Jul;74(14):6652-8
PMID: 10864681
-
The Epstein-Barr virus latent membrane protein 1 induces interleukin-10 in Burkitt's lymphoma cells but not in Hodgkin's cells involving the p38/SAPK2 pathway.
Virology. 2001 Feb 15;280(2):183-98
PMID: 11162833
-
Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors.
J Virol. 2001 Mar;75(6):2929-37
PMID: 11222718
-
STAT proteins: novel molecular targets for cancer drug discovery.
Oncogene. 2000 Dec 27;19(56):6613-26
PMID: 11426647
-
STAT3 is constitutively activated in Hodgkin cell lines.
Blood. 2001 Aug 1;98(3):762-70
PMID: 11468177
-
Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation.
J Biol Chem. 2001 Nov 30;276(48):45443-55
PMID: 11579100
-
Signalling downstream of activated mammalian Notch.
Nature. 1995 Sep 28;377(6547):355-8
PMID: 7566092
-
Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2.
Mol Cell Biol. 1996 Mar;16(3):952-9
PMID: 8622698
-
Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin's disease.
Blood. 1996 Apr 1;87(7):2918-29
PMID: 8639912
-
Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia.
Oncogene. 1996 Jul 18;13(2):247-54
PMID: 8710363
-
Requirements for interleukin-4-induced gene expression and functional characterization of Stat6.
Mol Cell Biol. 1996 Oct;16(10):5811-20
PMID: 8816495
-
Expression of the Epstein Barr virus transforming protein LMP1 causes a rapid and transient stimulation of the Bcl-2 homologue Mcl-1 levels in B-cell lines.
Cancer Res. 1996 Oct 15;56(20):4610-3
PMID: 8840972
-
Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation.
Mol Cell Biol. 1996 Dec;16(12):7098-108
PMID: 8943365
-
CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr Virus-encoded LMP1: involvement of TRAF3 as a common mediator.
Oncogene. 1996 Nov 21;13(10):2243-54
PMID: 8950992
-
Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene.
J Virol. 1996 Dec;70(12):8653-9
PMID: 8970991
-
Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
Oncogene. 1997 Jun 19;14(24):2899-916
PMID: 9205097
-
Modulation of interleukin-6 expression in Hodgkin and Reed-Sternberg cells by Epstein-Barr virus.
J Pathol. 1997 Jul;182(3):299-306
PMID: 9349232
-
The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB.
Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12592-7
PMID: 9356494
-
Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade.
EMBO J. 1997 Nov 3;16(21):6478-85
PMID: 9351829
-
An ATF/CRE element mediates both EBNA2-dependent and EBNA2-independent activation of the Epstein-Barr virus LMP1 gene promoter.
J Virol. 1998 Feb;72(2):1365-76
PMID: 9445037
-
Stat3 activation by Src induces specific gene regulation and is required for cell transformation.
Mol Cell Biol. 1998 May;18(5):2545-52
PMID: 9566874
-
Stat3 activation is required for cellular transformation by v-src.
Mol Cell Biol. 1998 May;18(5):2553-8
PMID: 9566875
-
A fusion of the EBV latent membrane protein-1 (LMP1) transmembrane domains to the CD40 cytoplasmic domain is similar to LMP1 in constitutive activation of epidermal growth factor receptor expression, nuclear factor-kappa B, and stress-activated protein kinase.
J Immunol. 1998 Feb 1;160(3):1116-21
PMID: 9570524
-
The NPC derived C15 LMP1 protein confers enhanced activation of NF-kappa B and induction of the EGFR in epithelial cells.
Oncogene. 1998 Apr 9;16(14):1869-77
PMID: 9583684
-
Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta.
Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):10106-11
PMID: 9707608
-
STAT3 is required for the gp130-mediated full activation of the c-myc gene.
J Exp Med. 1999 Jan 4;189(1):63-73
PMID: 9874564
-
Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2.
J Virol. 1999 Feb;73(2):1023-35
PMID: 9882303
-
Cutting edge: protective effects of notch-1 on TCR-induced apoptosis.
J Immunol. 1999 Jan 15;162(2):635-8
PMID: 9916679
-
Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells.
Immunity. 1999 Jan;10(1):105-15
PMID: 10023775
-
Interleukin-10 inhibits expression of both interferon alpha- and interferon gamma- induced genes by suppressing tyrosine phosphorylation of STAT1.
Blood. 1999 Mar 1;93(5):1456-63
PMID: 10029571
-
Silencing of the Epstein-Barr virus latent membrane protein 1 gene by the Max-Mad1-mSin3A modulator of chromatin structure.
J Virol. 1999 Apr;73(4):2983-93
PMID: 10074148
-
Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis.
J Exp Med. 1999 Apr 19;189(8):1229-42
PMID: 10209040
-
Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2.
J Virol. 2002 Jan;76(1):232-42
PMID: 11739688
-
The Epstein-Barr virus latent membrane protein 1 putative Janus kinase 3 (JAK3) binding domain does not mediate JAK3 association or activation in B-lymphoma or lymphoblastoid cell lines.
J Virol. 2002 Jan;76(1):455-9
PMID: 11739714
-
Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention.
Clin Cancer Res. 2002 Apr;8(4):945-54
PMID: 11948098
-
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis.
Oncogene. 2002 Mar 27;21(13):2000-8
PMID: 11960372
-
Cytokine signaling in 2002: new surprises in the Jak/Stat pathway.
Cell. 2002 Apr;109 Suppl:S121-31
PMID: 11983158
-
Series introduction. JAK-STAT signaling in human disease.
J Clin Invest. 2002 May;109(9):1133-7
PMID: 11994400
-
Signaling through the JAK/STAT pathway, recent advances and future challenges.
Gene. 2002 Feb 20;285(1-2):1-24
PMID: 12039028
-
Smart drugs: tyrosine kinase inhibitors in cancer therapy.
Cancer Cell. 2002 Mar;1(2):117-23
PMID: 12086869
-
The role of interleukin 13 in classical Hodgkin lymphoma.
Leuk Lymphoma. 2002 Jun;43(6):1203-10
PMID: 12152987
-
Epstein-Barr virus EBNA2 blocks Nur77- mediated apoptosis.
Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11878-83
PMID: 12195020
-
Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2.
Nat Med. 2002 Oct;8(10):1098-104
PMID: 12219084
-
Cytogenetic studies on an epithelial cell line derived from poorly differentiated nasopharyngeal carcinoma.
Int J Cancer. 1983 May 15;31(5):587-90
PMID: 6852976
-
Establishment of Epstein-Barr virus (EBV)-associated nuclear antigen (EBNA)-positive nasopharyngeal carcinoma hybrid cell line (NPC-KT).
Arch Otorhinolaryngol. 1984;239(1):87-92
PMID: 6318711
-
Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells.
J Virol. 1985 Sep;55(3):710-20
PMID: 2991591
-
An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.
Cell. 1985 Dec;43(3 Pt 2):831-40
PMID: 3000618
-
Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells.
J Virol. 1990 Jun;64(6):3033-41
PMID: 2159561
-
Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.
J Virol. 1990 Jul;64(7):3407-16
PMID: 2352328
-
EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus.
J Virol. 1991 May;65(5):2164-9
PMID: 1850003
-
Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation.
J Virol. 1991 May;65(5):2545-54
PMID: 1850028
-
Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death.
Cell. 1991 Jun 28;65(7):1107-15
PMID: 1648447
-
Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression.
J Virol. 1991 Dec;65(12):6765-71
PMID: 1658373
-
Identification of critical cis elements involved in mediating Epstein-Barr virus nuclear antigen 2-dependent activity of an enhancer located upstream of the viral BamHI C promoter.
J Virol. 1992 May;66(5):2846-52
PMID: 1313905
-
Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity.
J Virol. 1992 Nov;66(11):6496-501
PMID: 1404600
-
The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B.
J Biol Chem. 1992 Dec 5;267(34):24157-60
PMID: 1332946
-
The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter.
EMBO J. 1993 Jan;12(1):167-75
PMID: 8381349
-
Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa.
Science. 1994 Jul 1;265(5168):92-5
PMID: 8016657
-
The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein.
Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7568-72
PMID: 8052621
-
Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes.
J Virol. 1994 Nov;68(11):6947-58
PMID: 7933076
-
Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-J kappa, the homologue of Drosophila Suppressor of Hairless.
EMBO J. 1994 Oct 17;13(20):4973-82
PMID: 7957063
-
Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1.
J Virol. 1995 Jan;69(1):253-62
PMID: 7983717
-
The Spi-1/PU.1 and Spi-B ets family transcription factors and the recombination signal binding protein RBP-J kappa interact with an Epstein-Barr virus nuclear antigen 2 responsive cis-element.
EMBO J. 1994 Dec 1;13(23):5624-32
PMID: 7988559
-
The human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements.
EMBO J. 1994 Dec 1;13(23):5633-8
PMID: 7988560
-
The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain.
Oncogene. 1995 Feb 2;10(3):549-60
PMID: 7845680
-
The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family.
Cell. 1995 Feb 10;80(3):389-99
PMID: 7859281
-
Stimulation of NF-kappa B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus.
J Virol. 1995 May;69(5):2968-76
PMID: 7707523
-
Masking of the CBF1/RBPJ kappa transcriptional repression domain by Epstein-Barr virus EBNA2.
Science. 1995 Apr 28;268(5210):560-3
PMID: 7725102
-
The Epstein-Barr virus 3.5-kilobase latent membrane protein 1 mRNA initiates from a TATA-Less promoter within the first terminal repeat.
J Virol. 1995 Jul;69(7):4577-81
PMID: 7769727
-
Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein.
Science. 1995 Jul 7;269(5220):81-3
PMID: 7541555
-
Expression of Epstein-Barr virus BamHI-A rightward transcripts in latently infected B cells from peripheral blood.
Blood. 1999 May 1;93(9):3026-32
PMID: 10216099
-
Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production.
J Biol Chem. 1999 Jun 4;274(23):16085-96
PMID: 10347160
-
Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins.
EMBO J. 1999 Jun 1;18(11):3064-73
PMID: 10357818
-
The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation.
Mol Cell Biol. 1999 Aug;19(8):5759-67
PMID: 10409763
-
STAT5 activation by BCR-Abl contributes to transformation of K562 leukemia cells.
Blood. 1999 Aug 1;94(3):1108-12
PMID: 10419904
-
The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity.
Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9339-44
PMID: 10430944
-
Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus.
Int J Cancer. 1999 Sep 24;83(1):121-6
PMID: 10449618
-
Stat3 as an oncogene.
Cell. 1999 Aug 6;98(3):295-303
PMID: 10458605
-
IFN-alpha activates Stat6 and leads to the formation of Stat2:Stat6 complexes in B cells.
J Immunol. 1999 Oct 1;163(7):3834-41
PMID: 10490982
-
Additive effect of Sp1 and Sp3 in regulation of the ED-L1E promoter of the EBV LMP 1 gene in human epithelial cells.
Virology. 1999 Sep 1;261(2):288-94
PMID: 10497114
-
Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses.
Science. 1999 Oct 8;286(5438):300-3
PMID: 10514374
-
Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.
Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):9150-4
PMID: 8415670
-
The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein.
Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9237-41
PMID: 8415684